Therefore, this study aimed to investigate whether the SII value before brain radiotherapy and its dynamic changes during brain radiotherapy were predictive for OS in patients with BMs from EGFR-mutant lung adenocarcinoma. The gene discussed is EGFR; the disease is lung adenocarcinoma.